Seeking AlphaGilead Sciences: Strong Buy On Pipeline Momentum And Cost Discipline (NASDAQ:GILD)10 days agoMore
Yahoo FinanceRBC Capital Lifts Gilead Sciences (GILD) PT to $95 On Insights From a 2022 Patient Survey10 days agoBy Maham FatimaMore
Daily Chhattisgarh NewsGilead Sciences Stock Skyrockets Over 65% in a Year, Highlighting Powerful Growth and Long-Term Value5 days agoBy Akshat GuptaMore
Full CoverageFull Coverage